Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study

The safety and efficacy of tocilizumab for the treatment of severe respiratory symptoms due to COVID-19 remain uncertain, in particular among solid organ transplant (SOT) recipients. Thus, we evaluated the clinical characteristics and outcomes of 29 hospitalized SOT recipients who received tocilizum...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Transplant
Main Authors: Pereira, Marcus R., Aversa, Meghan M., Farr, Maryjane A., Miko, Benjamin A., Aaron, Justin G., Mohan, Sumit, Cohen, David J., Husain, Syed A., Ratner, Lloyd E., Arcasoy, Selim, Uriel, Nir, Zheng, Elizabeth X., Fox, Alyson N., Tsapepas, Demetra S., Emond, Jean C., Verna, Elizabeth C.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Fag:
Brief Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537322/
https://ncbi.nlm.nih.gov/pubmed/32946668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16314
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker